« Back
Home /
Apabetalone

Apabetalone

Manufacturer	TargetMol
Category	Oncology Neuroscience Molecular Targets for Neuroscience Aging & Neurological Disorders Protein Aggregation, Clearance & Misfolding By Cell Type Adenocarcinoma Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	10mg
Item no.	TMO-T2480-10mg
Targets	APP
CASRN	1044870-39-4
eClass 6.1	32169090
eClass 9.0	32169090
Available
Short Description	RVX-208, an effective BET bromodomain inhibitor, has been investigated for the treatment of diabetes, atherosclerosis, and coronary artery disease.
Shipping	cool pack
Storage	-20°
Target names or alias	RVX000222 , RVX-208
Molecular Weight	370, 4
Pathway	Microbiology/Virology\|\|\|Chromatin/Epigenetic\|\|\|Proteases/Proteasome
Target	Epigenetic Reader Domain\|\|\|HIV Protease

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10mg

available

Delivery expected until 5/16/2024